Dalton, Greiner, Hartman, Maher & Co’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,469,973
Closed -$23.8M 170
2018
Q4
$23.8M Sell
2,469,973
-778,712
-24% -$8.68M 1.78% 8
2018
Q3
$46.3M Buy
3,248,685
+74,174
+2% +$1.01M 2.31% 1
2018
Q2
$38.1M Buy
3,174,511
+893,405
+39% +$11M 1.95% 1
2018
Q1
$28.2M Sell
2,281,106
-709,796
-24% -$10.1M 1.9% 4
2017
Q4
$43.5M Buy
2,990,902
+465,037
+18% +$6.46M 2.28% 2
2017
Q3
$35.9M Buy
2,525,865
+2,425,865
+2,426% +$31.4M 2.01% 1
2017
Q2
$1.28M Buy
+100,000
New +$1.21M 0.07% 156

Other funds holding MDRX

Dalton, Greiner, Hartman, Maher & Co's MDRX Position: Q1 2019 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2019, closing a stake of 2,469,973 shares — an estimated $23.8M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in MDRX in Q2 2017 and held it in 7 quarters. The position peaked at $46.3M in Q3 2018. 225 funds tracked by Wall St. Rank hold MDRX as of Q1 2019.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Veradigm Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 2,469,973 Veradigm Inc. Common Stock shares in Q1 2019, an estimated $23.8M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Veradigm Inc. Common Stock in Q2 2017 and held it in 7 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's Veradigm Inc. Common Stock position peaked at $46.3M in Q3 2018.
  • 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2019.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q1 2019, filed 8 Apr 2019.